Similarly, of the 13 patients with non-significant CE findings P1, 11 85% had no recurrence of bleeding during follow-up, none had recurrences of iron deficiency anemia and only 2 15.4% had obvious recurrent bleeding.
De igual forma, de los 13 pacientes con hallazgos no significativos P1 en CE, 11 85% no presentaron recurrencia de sangrado durante el seguimiento, ninguno presentó recurrencia de anemia ferropénica y solo 2 15,4% tuvieron sangrado evidente recurrente.